Drug coated Balloon Catheter Market Size, Share, Trends, Growth Outlook

Drug coated Balloon Catheter Market is estimated to increase at a growth rate of 10.2% CAGR over the forecast period from 2024 to 2030.

The Drug coated Balloon Catheter Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Type (Paclitaxel, Sirolimus), By Product (Coronary Artery Disease, Peripheral Vascular Disease), By End-User (Hospital, Clinics, Ambulatory Surgical Centers).

An Introduction to Drug coated Balloon Catheter Market in 2024

The Drug Coated Balloon Catheter market in 2024 serves the demand for minimally invasive medical devices used in the treatment of peripheral artery disease (PAD) and coronary artery disease (CAD) by delivering anti-restenotic drugs directly to arterial walls to inhibit neointimal hyperplasia and prevent vessel re-narrowing after angioplasty. Drug-coated balloon catheters consist of a balloon coated with an antiproliferative drug, such as paclitaxel or sirolimus, which is released locally during balloon inflation to inhibit smooth muscle cell proliferation and reduce the risk of restenosis following balloon angioplasty. Market dynamics are driven by factors such as the increasing prevalence of cardiovascular diseases, advancements in balloon catheter design and drug formulations, and the demand for durable and effective treatment options for patients with obstructive arterial lesions. Collaboration between medical device manufacturers, interventional cardiologists, and regulatory agencies drives innovation and market expansion in drug-coated balloon catheters, supporting improved clinical outcomes and long-term patency rates in patients undergoing endovascular interventions for peripheral and coronary artery disease.

Drug coated Balloon Catheter Market Trend: Expansion of Minimally Invasive Treatment Options

A prominent trend in the Drug-Coated Balloon Catheter market is the expansion of minimally invasive treatment options for cardiovascular diseases. Drug-coated balloon catheters offer a less invasive alternative to traditional treatments such as angioplasty and stenting for the management of coronary artery disease and peripheral artery disease. These devices deliver a therapeutic drug coating directly to the site of arterial blockages, inhibiting restenosis and promoting vessel patency without leaving behind permanent implants. As patients and healthcare providers increasingly seek minimally invasive interventions that reduce procedural risks, hospital stays, and recovery times, the demand for drug-coated balloon catheters as effective and safe treatment modalities continues to grow, driving market expansion in the Drug-Coated Balloon Catheter segment.

Drug coated Balloon Catheter Market Driver: Rising Prevalence of Cardiovascular Diseases

A key driver in the Drug-Coated Balloon Catheter market is the rising prevalence of cardiovascular diseases globally. Cardiovascular diseases, including coronary artery disease, peripheral artery disease, and in-stent restenosis, remain leading causes of morbidity and mortality worldwide. As the population ages and risk factors such as obesity, diabetes, and hypertension become more prevalent, the incidence of cardiovascular diseases continues to increase. Drug-coated balloon catheters offer a targeted and effective treatment option for restoring blood flow in diseased arteries, reducing the need for repeat interventions and improving patient outcomes. The growing burden of cardiovascular diseases drives the demand for innovative medical devices like drug-coated balloon catheters that address unmet clinical needs and improve the quality of care for patients with vascular conditions.

Drug coated Balloon Catheter Market Opportunity: Development of Next-Generation Drug-Coated Balloon Technologies

One potential opportunity in the Drug-Coated Balloon Catheter market lies in the development of next-generation technologies that enhance drug delivery efficiency, efficacy, and safety. Researchers and manufacturers are exploring novel drug formulations, coating materials, and balloon designs to improve drug adherence to arterial walls, enhance drug release kinetics, and minimize systemic drug exposure. Additionally, advancements in balloon catheter technologies such as drug-eluting balloons with bioresorbable coatings, drug-releasing microneedles, and drug-loaded nanoparticles offer opportunities to optimize treatment outcomes and reduce the risk of adverse events. By investing in the development of innovative drug-coated balloon technologies, companies can differentiate their products, expand market share, and address evolving clinical needs in the treatment of cardiovascular diseases.

Drug coated Balloon Catheter Market Segmentation

By Type
Paclitaxel
Sirolimus
By Product
Coronary Artery Disease
Peripheral Vascular Disease
By End-User
Hospital
Clinics
Ambulatory Surgical Centers
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Drug coated Balloon Catheter Market Companies

B. Braun SE
Bayer AG
Biosensors International Group
BIOTRONIK
Boston Scientific Corp
Caliber Therapeutics
Concept Medical Research
Eurocor GmbH
iVascular
Medtronic plc

 

 

Reasons to Buy the Drug coated Balloon Catheter Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Drug coated Balloon Catheter Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Drug coated Balloon Catheter Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Drug coated Balloon Catheter Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Drug coated Balloon Catheter Market Size Outlook, $ Million, 2021 to 2030
3.2 Drug coated Balloon Catheter Market Outlook by Type, $ Million, 2021 to 2030
3.3 Drug coated Balloon Catheter Market Outlook by Product, $ Million, 2021 to 2030
3.4 Drug coated Balloon Catheter Market Outlook by Application, $ Million, 2021 to 2030
3.5 Drug coated Balloon Catheter Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Drug coated Balloon Catheter Market Industry
4.2 Key Market Trends in Drug coated Balloon Catheter Market Industry
4.3 Potential Opportunities in Drug coated Balloon Catheter Market Industry
4.4 Key Challenges in Drug coated Balloon Catheter Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Drug coated Balloon Catheter Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Drug coated Balloon Catheter Market Outlook By Segments
7.1 Drug coated Balloon Catheter Market Outlook by Segments
By Type
Paclitaxel
Sirolimus
By Product
Coronary Artery Disease
Peripheral Vascular Disease
By End-User
Hospital
Clinics
Ambulatory Surgical Centers

8 North America Drug coated Balloon Catheter Market Analysis And Outlook To 2030
8.1 Introduction to North America Drug coated Balloon Catheter Markets in 2024
8.2 North America Drug coated Balloon Catheter Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Drug coated Balloon Catheter Market size Outlook by Segments, 2021-2030
By Type
Paclitaxel
Sirolimus
By Product
Coronary Artery Disease
Peripheral Vascular Disease
By End-User
Hospital
Clinics
Ambulatory Surgical Centers

9 Europe Drug coated Balloon Catheter Market Analysis And Outlook To 2030
9.1 Introduction to Europe Drug coated Balloon Catheter Markets in 2024
9.2 Europe Drug coated Balloon Catheter Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Drug coated Balloon Catheter Market Size Outlook By Segments, 2021-2030
By Type
Paclitaxel
Sirolimus
By Product
Coronary Artery Disease
Peripheral Vascular Disease
By End-User
Hospital
Clinics
Ambulatory Surgical Centers

10 Asia Pacific Drug coated Balloon Catheter Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Drug coated Balloon Catheter Markets in 2024
10.2 Asia Pacific Drug coated Balloon Catheter Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Drug coated Balloon Catheter Market size Outlook by Segments, 2021-2030
By Type
Paclitaxel
Sirolimus
By Product
Coronary Artery Disease
Peripheral Vascular Disease
By End-User
Hospital
Clinics
Ambulatory Surgical Centers

11 South America Drug coated Balloon Catheter Market Analysis And Outlook To 2030
11.1 Introduction to South America Drug coated Balloon Catheter Markets in 2024
11.2 South America Drug coated Balloon Catheter Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Drug coated Balloon Catheter Market size Outlook by Segments, 2021-2030
By Type
Paclitaxel
Sirolimus
By Product
Coronary Artery Disease
Peripheral Vascular Disease
By End-User
Hospital
Clinics
Ambulatory Surgical Centers

12 Middle East And Africa Drug coated Balloon Catheter Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Drug coated Balloon Catheter Markets in 2024
12.2 Middle East and Africa Drug coated Balloon Catheter Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Drug coated Balloon Catheter Market size Outlook by Segments, 2021-2030
By Type
Paclitaxel
Sirolimus
By Product
Coronary Artery Disease
Peripheral Vascular Disease
By End-User
Hospital
Clinics
Ambulatory Surgical Centers

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
B. Braun SE
Bayer AG
Biosensors International Group
BIOTRONIK
Boston Scientific Corp
Caliber Therapeutics
Concept Medical Research
Eurocor GmbH
iVascular
Medtronic plc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Type
Paclitaxel
Sirolimus
By Product
Coronary Artery Disease
Peripheral Vascular Disease
By End-User
Hospital
Clinics
Ambulatory Surgical Centers